<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01002053</url>
  </required_header>
  <id_info>
    <org_study_id>UHN 09-0803-AE</org_study_id>
    <nct_id>NCT01002053</nct_id>
  </id_info>
  <brief_title>Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?</brief_title>
  <official_title>Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of regional anesthesia for nerve block in diabetic patients with peripheral
      neuropathy is currently made on a case-by-case basis, also remains underlying uncertainty
      regarding the preferred technique and the likelihood of block-related nerve injury. For this
      many diabetic patients with otherwise healthy nerves may receive general anesthesia instead
      of regional anesthesia, thus giving up the benefits associated with the latter technique,
      including a decrease in health complications and superior analgesia following the operation.
      Ultrasound is used to identify the target nerve and guide needle insertion for nerve blocks,
      may be a useful tool to detect the presence and severity of neuropathy prior to block
      placement, a recent study demonstrated a statistically significant increase in the
      sonographic cross-sectional area of the posterior tibial nerve (PTN) in all diabetic patients
      who had abnormal motor transmission on nerve conduction studies. For regional
      anesthesiologists, the ultimate goal of detecting peripheral neuropathy and in particular,
      diabetic neuropathy by US is to avoid nerve injury. To do so, the association between
      US-detected diabetic neuropathy and block-related nerve damage must be first established,
      hence the purpose of this study. We aim to examine whether the cross-sectional area of PTN as
      assessed by preoperative US can predict nerve injury as assessed by worsening nerve
      conduction studies following PTN block inpatients scheduled to receive an ankle block. A
      further subgroup analysis will be performed in diabetic patients.

      We hypothesize that the cross sectional area of the PTN will correlate with motor conduction
      velocity on nerve conduction studies (NCS) following PTN block in patients with peripheral
      neuropathy. All eligible patients will undergo NCS to confirm or exclude distal neuropathy.
      Patients without neuropathy will be excluded from further participation in this study. Also
      excluded will be diabetic patients with neuropathy caused by genetic, metabolic and
      inflammatory diseases as well as toxic agents and drug induced. A systematic US examination
      of the PTN will be performed for all patients. After Block administration at surgery day the
      block successes will be assessed and for the purposes of the present study, patients in whom
      the block was not successful will be excluded from further intervention and data analyses.
      Eight weeks after surgery, all study patients will return to hospital for repeat NCS and US.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Interval worsening of the severity of neuropathy</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>New functional neuropathy defined as any new sensory or motor deficit compared to preoperatively.</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Diabetic Neuropathy</condition>
  <arm_group>
    <arm_group_label>Diabetics with peripheral neuropathy</arm_group_label>
    <description>Patients with diabetes and peripheral neuropathy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nerve conduction study and Ultrasound of the PTN</intervention_name>
    <description>Nerve Conduction studies and ultrasound of PTN will be performed to the patient before the operation and 8 weeks postoperatively.</description>
    <arm_group_label>Diabetics with peripheral neuropathy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Diabetic and non-diabetic patients undergoing foot surgery involving regional
        anesthesia/nerve blockade.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing PTN block for foot surgery

          -  Type I diabetic patients (diagnosed more than 5 years), and II diabetic patients with
             demonstrated peripheral neuropathy

          -  ASA I-III

        Exclusion Criteria:

          -  Non-diabetic neuropathy caused by genetic, metabolic and inflammatory diseases as well
             as toxic agents and drug induced (e.g. chemotherapy agents)

          -  Psychiatric history

          -  Allergy to local anesthetics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheila Riazi, MD, MSc, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network - University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto Western Hospital, University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet. 1973 Aug 18;2(7825):359-62.</citation>
    <PMID>4124532</PMID>
  </reference>
  <reference>
    <citation>Blumenthal S, Borgeat A, Maurer K, Beck-Schimmer B, Kliesch U, Marquardt M, Urech J. Preexisting subclinical neuropathy as a risk factor for nerve injury after continuous ropivacaine administration through a femoral nerve catheter. Anesthesiology. 2006 Nov;105(5):1053-6.</citation>
    <PMID>17065901</PMID>
  </reference>
  <reference>
    <citation>Zochodne DW. Diabetic polyneuropathy: an update. Curr Opin Neurol. 2008 Oct;21(5):527-33. doi: 10.1097/WCO.0b013e32830b84cb. Review.</citation>
    <PMID>18769245</PMID>
  </reference>
  <reference>
    <citation>Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ 3rd. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992 Jun;42(6):1164-70.</citation>
    <PMID>1603343</PMID>
  </reference>
  <reference>
    <citation>Kalichman MW, Calcutt NA. Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology. 1992 Nov;77(5):941-7.</citation>
    <PMID>1443749</PMID>
  </reference>
  <reference>
    <citation>Hebl JR, Kopp SL, Schroeder DR, Horlocker TT. Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg. 2006 Nov;103(5):1294-9.</citation>
    <PMID>17056972</PMID>
  </reference>
  <reference>
    <citation>Kroin JS, Buvanendran A, Williams DK, Wagenaar B, Moric M, Tuman KJ, Kerns JM. Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats. Reg Anesth Pain Med. 2010 Jul-Aug;35(4):343-50.</citation>
    <PMID>20607875</PMID>
  </reference>
  <reference>
    <citation>Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, Angelillo IF, Mosteller F. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998 Mar;86(3):598-612.</citation>
    <PMID>9495424</PMID>
  </reference>
  <reference>
    <citation>Urwin SC, Parker MJ, Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth. 2000 Apr;84(4):450-5. Erratum in: Br J Anaesth 2002 Apr;88(4):619.</citation>
    <PMID>10823094</PMID>
  </reference>
  <reference>
    <citation>Hadzic A, Arliss J, Kerimoglu B, Karaca PE, Yufa M, Claudio RE, Vloka JD, Rosenquist R, Santos AC, Thys DM. A comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries. Anesthesiology. 2004 Jul;101(1):127-32.</citation>
    <PMID>15220781</PMID>
  </reference>
  <reference>
    <citation>Chan VW, Peng PW, Kaszas Z, Middleton WJ, Muni R, Anastakis DG, Graham BA. A comparative study of general anesthesia, intravenous regional anesthesia, and axillary block for outpatient hand surgery: clinical outcome and cost analysis. Anesth Analg. 2001 Nov;93(5):1181-4.</citation>
    <PMID>11682392</PMID>
  </reference>
  <reference>
    <citation>Alshami AM, Cairns CW, Wylie BK, Souvlis T, Coppieters MW. Reliability and size of the measurement error when determining the cross-sectional area of the tibial nerve at the tarsal tunnel with ultrasonography. Ultrasound Med Biol. 2009 Jul;35(7):1098-102. doi: 10.1016/j.ultrasmedbio.2009.01.011. Epub 2009 May 7.</citation>
    <PMID>19427097</PMID>
  </reference>
  <reference>
    <citation>Cartwright MS, Passmore LV, Yoon JS, Brown ME, Caress JB, Walker FO. Cross-sectional area reference values for nerve ultrasonography. Muscle Nerve. 2008 May;37(5):566-71. doi: 10.1002/mus.21009.</citation>
    <PMID>18351581</PMID>
  </reference>
  <reference>
    <citation>Lee D, Dauphinée DM. Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompression. J Am Podiatr Med Assoc. 2005 Sep-Oct;95(5):433-7.</citation>
    <PMID>16166459</PMID>
  </reference>
  <reference>
    <citation>Vijayan J, Therimadasamy AK, Teoh HL, Chan YC, Wilder-Smith EP. Sonography as an aid to neurophysiological studies in diagnosing tarsal tunnel syndrome. Am J Phys Med Rehabil. 2009 Jun;88(6):500-1. doi: 10.1097/PHM.0b013e3181a5b94b.</citation>
    <PMID>19454856</PMID>
  </reference>
  <reference>
    <citation>Watanabe T, Ito H, Morita A, Uno Y, Nishimura T, Kawase H, Kato Y, Matsuoka T, Takeda J, Seishima M. Sonographic evaluation of the median nerve in diabetic patients: comparison with nerve conduction studies. J Ultrasound Med. 2009 Jun;28(6):727-34.</citation>
    <PMID>19470812</PMID>
  </reference>
  <reference>
    <citation>Watanabe T, Ito H, Sekine A, Katano Y, Nishimura T, Kato Y, Takeda J, Seishima M, Matsuoka T. Sonographic evaluation of the peripheral nerve in diabetic patients: the relationship between nerve conduction studies, echo intensity, and cross-sectional area. J Ultrasound Med. 2010 May;29(5):697-708.</citation>
    <PMID>20427781</PMID>
  </reference>
  <reference>
    <citation>Harati Y. Diabetic neuropathies: unanswered questions. Neurol Clin. 2007 Feb;25(1):303-17. Review.</citation>
    <PMID>17324729</PMID>
  </reference>
  <reference>
    <citation>Misur I, Zarković K, Barada A, Batelja L, Milicević Z, Turk Z. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol. 2004 Dec;41(4):158-66.</citation>
    <PMID>15660198</PMID>
  </reference>
  <reference>
    <citation>Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 Jul 13;333(2):89-94.</citation>
    <PMID>7777034</PMID>
  </reference>
  <reference>
    <citation>Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol. 2003 Jul;114(7):1167-75. Review.</citation>
    <PMID>12842711</PMID>
  </reference>
  <reference>
    <citation>Vinik AI, Bril V, Litchy WJ, Price KL, Bastyr EJ 3rd; MBBQ Study Group. Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy. Muscle Nerve. 2005 Nov;32(5):619-25.</citation>
    <PMID>16116628</PMID>
  </reference>
  <reference>
    <citation>Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract. 2001 Nov;54(2):115-28.</citation>
    <PMID>11640995</PMID>
  </reference>
  <reference>
    <citation>Yesildag A, Kutluhan S, Sengul N, Koyuncuoglu HR, Oyar O, Guler K, Gulsoy UK. The role of ultrasonographic measurements of the median nerve in the diagnosis of carpal tunnel syndrome. Clin Radiol. 2004 Oct;59(10):910-5.</citation>
    <PMID>15451351</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2009</study_first_submitted>
  <study_first_submitted_qc>October 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2009</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>neuropathy</keyword>
  <keyword>ankle block</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>ultrasound</keyword>
  <keyword>nerve localization</keyword>
  <keyword>Nerve localization in patients undergoing foot surgery and having ankle block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

